The SFTPB gene gives your body instructions to make surfactant protein B, a substance that helps keep the tiny air sacs in the lungs open so breathing is easier. If this gene does not work properly, the lungs may not make enough working surfactant, and oxygen has a harder time moving into the blood. In babies with two nonworking copies, this can cause breathing failure soon after birth. Some other variants in the SFTPB gene may also play a role in lung problems later in life.
What is a gene?
Genes are stretches of DNA that give cells instructions they can use to make molecules or regulate processes in the body. Some carry the directions for producing proteins, the working parts of cells. Others mostly help control when certain processes take place, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape your response to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
SFTPBGene function
What if the gene works
The SFTPB gene helps make surfactant protein B in the lungs. This protein helps the tiny air sacs stay open, so breathing is easier and oxygen can move into the blood.
Risk
What if the gene does not work
Variants in the SFTPB gene can disrupt lung surfactant, the slippery material that keeps air sacs open. More severe variants often cause severe breathing failure soon after birth, while milder variants may lead to later onset chronic lung disease.
Treatment
What does that mean for your treatment
At present, no SFTPB-specific treatment or drug choice is established for people with pathogenic variants in the SFTPB gene. The SFTPB gene is being studied for surfactant replacement and gene therapies, but these are not yet standard care.
Conditions associated with SFTPB
Gene function
What if the gene works
Breathing depends on a thin, slippery coating inside the lungs. The SFTPB gene helps lung cells make surfactant protein B, a key part of surfactant, the material that coats the tiny air sacs. This helps explain what the SFTPB gene does in the lungs during everyday breathing.
The protein from the SFTPB gene helps lung cells package, process, and release surfactant in a usable form. This keeps the lung lining ready for repeated breathing cycles.
Surfactant protein B helps surfactant spread into a thin film over the tiny air sacs. That slippery film lowers surface tension, so the sacs can open and close more smoothly.
By keeping the surfactant layer stable, this gene supports the tiny air sacs with each breath in and out. That helps more of the lung stay open for steady oxygen and carbon dioxide exchange.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more substantially and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SFTPB gene can make surfactant protein B too short, misfolded, or missing, which disrupts surfactant assembly in the lungs. In severe biallelic variants, cells may make little or no usable protein, which helps explain how SFTPB gene variants can cause newborn breathing problems. Milder variants may leave some protein activity, and this can be linked to a later start or a less severe course.
How variants are linked to conditions
Pathogenic variants in the SFTPB gene cause surfactant protein B deficiency, a rare inherited lung condition that usually affects newborns and can confirm an SFTPB-related diagnosis when two disease-causing variants are found. Some variants in the SFTPB gene have also been linked to childhood interstitial lung disease in babies or children who survive beyond the newborn period. This is a single-gene condition, not a common risk variant pattern, so the finding is diagnostic rather than a general increase in risk.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SFTPB, risk is mainly shaped by genetics rather than lifestyle. The chance of having a child with an SFTPB-related lung condition is higher when both parents carry a disease-causing change in the SFTPB gene, and this can be more likely in families with a known history or when parents are blood relatives.
Inheritance of SFTPB variants
SFTPB-related conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two disease-causing variants in the SFTPB gene, one from each parent, to be affected. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking how SFTPB gene variants are inherited, this recessive pattern is the key point, and it affects boys and girls equally.
What does my SFTPB result mean for my family?
For families with an SFTPB-related condition, the usual pattern is recessive, which means parents are often healthy carriers and siblings may also be carriers or, in some cases, have the condition. Close relatives may want to learn whether the same gene change runs in the family, especially when planning children. Children of someone with an SFTPB-related condition will usually be carriers unless the other parent also carries an SFTPB change.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SFTPB gene uses a blood sample or cheek swab to read the DNA code and look for changes linked to surfactant protein B deficiency. SFTPB genetic testing can confirm whether a known disease-causing variant is present, identify carrier status, or help clarify a diagnosis when a newborn has unexplained breathing problems.
When should I consider getting a genetic test?
Genetic testing for SFTPB may be worth considering if a full-term newborn has severe breathing problems soon after birth without a clear cause, especially if usual treatment is not helping. It can also help when a child or family has a history of unexplained serious lung disease or an earlier baby with the same problem.
A genetic result is only one part of your health story
Genetic results can provide useful insight, although the amount they reveal varies by the condition and the type of variant involved. Lifestyle, environment, age, and medical history, among other factors, also influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered with the rest of a person’s care. In other situations, a genetic result can give a clear answer. In areas like response to medications, these results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more quickly or more slowly, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person but causes side effects or limited benefit in another. These differences are common and are one part of the bigger picture alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SFTPB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines or side effects are best discussed with your doctor. Seek medical advice if breathing symptoms change, a new treatment seems to make symptoms worse, or you are worried about how a medicine is affecting you.
History
Throughout history, doctors described some newborns with severe breathing problems that did not match the usual pattern of prematurity. In the late 20th century, researchers studying inherited forms of neonatal lung disease traced one of these patterns to the SFTPB gene. From these first observations, research expanded steadily, linking rare SFTPB variants to a distinct cause of respiratory failure in full term and near term babies. This discovery helped explain why some infants did not improve as expected with standard supportive care. It also became an important milestone in neonatal genetics, connecting careful bedside observation with gene based diagnosis.